1.2200
+0.3400
+(38.64%)
At close: 9:55:01 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 2 | 4 | 4 |
| Avg. Estimate | 2.4M | -- | 7.41M | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 4.82M | -- | 11.55M | -- |
| Year Ago Sales | 325.04k | 6.44M | 6.23M | 7.41M |
| Sales Growth (year/est) | 637.22% | -100.00% | 18.90% | -100.00% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 4PKB.F | -- | -- | -- | -- |
| S&P 500 | 15.59% | 7.50% | 10.67% | 14.09% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 12/20/2024 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 12/12/2024 |
| Downgrade | JMP Securities: Market Outperform to Market Perform | 12/11/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 8/21/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/28/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/21/2024 |
Related Tickers
NRXBF NUREXONE BIOLOGIC INC
0.3960
-5.71%
OSE.PA OSE Immunotherapeutics SA
6.64
+0.15%
AKTX Akari Therapeutics, Plc
0.9201
+1.11%
SLGL Sol-Gel Technologies Ltd.
0.5550
+0.91%
SYRE Spyre Therapeutics, Inc.
19.00
-7.99%
UPB Upstream Bio, Inc.
7.66
-0.91%
BOLT Bolt Biotherapeutics, Inc.
0.4600
-3.10%
XNCR Xencor, Inc.
14.38
-0.48%
PRLD Prelude Therapeutics Incorporated
0.8084
+0.30%
APRE Aprea Therapeutics, Inc.
2.5500
-0.39%